Year To Quarter End Consolidated Statement Of Income

Mochida Pharmaceutical Co.,Ltd. - Filing #7595456

Concept 2022-04-01 to
2022-06-30
2021-04-01 to
2021-06-30
Year to quarter end consolidated statement of income
Statement of income
Net sales
27,692,000,000 JPY
27,362,000,000 JPY
Cost of sales
12,434,000,000 JPY
12,406,000,000 JPY
Gross profit (loss)
15,257,000,000 JPY
14,956,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
10,992,000,000 JPY
11,772,000,000 JPY
Operating profit (loss)
4,265,000,000 JPY
3,183,000,000 JPY
Non-operating income
Interest income
0 JPY
0 JPY
Dividend income
171,000,000 JPY
137,000,000 JPY
Non-operating income
201,000,000 JPY
190,000,000 JPY
Non-operating expenses
Non-operating expenses
51,000,000 JPY
7,000,000 JPY
Ordinary profit (loss)
4,415,000,000 JPY
3,366,000,000 JPY
Extraordinary income
Extraordinary income
JPY
526,000,000 JPY
Extraordinary losses
Loss on disaster
JPY
2,000,000 JPY
Extraordinary losses
1,000,000 JPY
76,000,000 JPY
Profit (loss) before income taxes
4,414,000,000 JPY
3,816,000,000 JPY
Income taxes
1,259,000,000 JPY
1,162,000,000 JPY
Profit (loss)
3,155,000,000 JPY
2,653,000,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
3,155,000,000 JPY
2,653,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
143,000,000 JPY
-182,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-10,000,000 JPY
-25,000,000 JPY
Other comprehensive income
133,000,000 JPY
-208,000,000 JPY
Comprehensive income
3,288,000,000 JPY
2,445,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
3,288,000,000 JPY
2,445,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.